Hydatid cyst of the liver in pregnancy: mode of delivery

Mode of delivery

Practical obstetric plan

• Manage jointly with maternal-fetal medicine, hepatobiliary surgery, infectious diseases, anesthesia, and neonatology.
• Define cyst size, site, daughter cysts, and complications using ultrasound and, when needed, MRI without gadolinium.
• Assess for biliary obstruction, infection, and rupture risk.
• Plan birth in a center able to manage sudden anaphylaxis, hemorrhage, emergency laparotomy, and urgent cesarean if required.
• Do not aspirate a suspected hydatid cyst casually, because leakage can cause dissemination and anaphylaxis.
• Definitive management may be observation until postpartum, PAIR/percutaneous treatment in selected cases, or surgery, depending on cyst stage, symptoms, and gestational age.
• Albendazole decisions require specialist input. It is commonly avoided in the first trimester unless maternal benefit clearly outweighs fetal risk.

One-line exam answer

For an uncomplicated hydatid cyst of the liver, vaginal delivery is permissible and cesarean section is done only for obstetric indications or when a large/complicated cyst poses substantial rupture risk. Cesarean is indicated if a pelvic hydatid cyst obstructs labor.

Recent guidance: hydatid disease in pregnancy

Key recommendations applicable to pregnancy

1. Refer to a multidisciplinary team
   • Obstetrics/maternal-fetal medicine, hepatobiliary surgery, infectious diseases/tropical medicine, radiology/interventional radiology, anesthesia, and neonatology.
   • Treatment is individualized by cyst stage, size, location, symptoms, gestational age, local expertise, and risk of rupture or biliary complications.
2. Stage the liver cyst with imaging
   • Ultrasound is the basis of WHO cyst staging: CE1 to CE5.
   • MRI can be used when anatomy or complications need clarification in pregnancy.
   • Inactive uncomplicated cysts, usually CE4-CE5, are generally managed with serial imaging using a watch-and-wait approach. The WHO advises avoiding surgery unless an inactive cyst produces complications such as portal hypertension.
3. Albendazole
   • Avoid in the first trimester. WHO lists albendazole as contraindicated in the first trimester and also cautions against it when the cyst is at risk of rupture.
   • In the second or third trimester, albendazole may be considered only when anticipated maternal benefit outweighs potential fetal risk.
   • WHO’s general adult CE regimen is continuous albendazole 10-15 mg/kg/day in two doses, maximum 400 mg twice daily, taken with a fatty meal. Duration depends on cyst stage and intervention, so it should not be prescribed without specialist oversight.
   • Monitor liver enzymes and blood counts during prolonged therapy. The CDC clinical guidance similarly states that use in pregnancy requires balancing fetal drug risk against maternal disease progression.
4. Percutaneous treatment
   • PAIR means puncture, aspiration, injection of a protoscolicidal agent, and re-aspiration.
   • It can be appropriate for selected uncomplicated hepatic CE1 or CE3a cysts in nonpregnant patients, usually with albendazole cover.
   • In pregnancy, it is a specialist decision only. It requires facilities able to treat anaphylaxis, bleeding, infection, leakage, and dissemination.
   • If a cyst has biliary communication, WHO advises against injecting a protoscolicidal agent into the cyst. Alternative catheter drainage, surgery, or medical management may be selected.
5. Surgery
   • For complicated hepatic cysts, including rupture, infection, significant biliary communication/obstruction, severe compression, or a high-risk symptomatic lesion, surgery is generally the preferred definitive treatment according to WHO best practice.
   • If maternal intervention cannot safely wait until postpartum, the second trimester is often the most favorable operative period, but emergencies are managed at any gestation.
6. Delivery planning
   • Neither WHO nor CDC recommends routine cesarean delivery solely because a woman has a liver hydatid cyst.
   • Vaginal birth is reasonable for a stable, nonobstructive, uncomplicated hepatic cyst when no obstetric indication for cesarean exists.
   • Cesarean delivery is considered for normal obstetric indications or individualized maternal concerns, such as a very large unstable cyst with major concern for rupture, or a pelvic cyst obstructing labor.

How strong is the pregnancy evidence?

• [Systematic Review, Tier 1, 2026] Kavari et al., Echinococcosis in Pregnancy: A Systematic Review on Complications, Management, and Outcomes PMID: 42462706. It included 120 pregnancies; the liver was involved in 69%. Watchful waiting was most common (50%), followed by surgery (18%), percutaneous treatment (12%), and albendazole alone (9%).
• [Observational study, 2018] Celik et al., Analysis of factors affecting outcomes of pregnancy complicated by Echinococcus PMID: 29785547. Larger cysts, active cysts, growth during pregnancy, and first-trimester albendazole exposure were associated with poorer fetal outcomes. The authors support close follow-up for low-risk disease and intervention for high-risk cases.

Practical bottom line